Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAST-STROKE JAPAN
jRCT1050260197Not yet recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Oct 2026
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of amiodarone, flecainide, propafenone, bepridil, pilsicainide and 3 more in Atrial fibrillation (AFib) and ischemic stroke (2 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Primary composite endpoint. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
amiodaroneflecainidepropafenonebepridilpilsicainide
03
Conditions
Atrial fibrillation (AFib)ischemic stroke
Beyond the preview
Go deeper on jRCT1050260197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1050260197.